These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9397426)

  • 1. Effects of divalproex sodium on 5-HT1A receptor function in healthy human males: hypothermic, hormonal, and behavioral responses to ipsapirone.
    Shiah IS; Yatham LN; Lam RW; Zis AP
    Neuropsychopharmacology; 1997 Dec; 17(6):382-90. PubMed ID: 9397426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls.
    Yatham LN; Shiah IS; Lam RW; Tam EM; Zis AP
    J Affect Disord; 1999 Aug; 54(3):295-301. PubMed ID: 10467974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects.
    Delva NJ; Brooks DL; Franklin M; al-Said K; Hawken ER; Merali Z; Lawson JS; Ravindran AV
    J Psychiatry Neurosci; 2002 Nov; 27(6):429-37. PubMed ID: 12491576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects.
    Gelfin Y; Lerer B; Lesch KP; Gorfine M; Allolio B
    Psychopharmacology (Berl); 1995 Aug; 120(3):356-64. PubMed ID: 8524984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects.
    Berlin I; Warot D; Legout V; Guillemant S; Schöllnhammer G; Puech AJ
    Clin Pharmacol Ther; 1998 Apr; 63(4):428-36. PubMed ID: 9585797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study.
    Cleare AJ; Forsling M; Bond AJ
    Int Clin Psychopharmacol; 1998 Jan; 13(1):23-32. PubMed ID: 9988364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol, hypothermic, and behavioral responses to ipsapirone in patients with bipolar depression and normal controls.
    Shiah IS; Yatham LN; Lam RW; Tam EM; Zis AP
    Neuropsychobiology; 1998; 38(1):6-12. PubMed ID: 9701716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antiglucocorticoid treatment on 5-HT1A function in depressed patients and healthy subjects.
    Price LH; Cappiello A; Malison RT; McDougle CJ; Pelton GH; Schöllnhammer G; Heninger GR
    Neuropsychopharmacology; 1997 Oct; 17(4):246-57. PubMed ID: 9326749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge.
    Lerer B; Gelfin Y; Gorfine M; Allolio B; Lesch KP; Newman ME
    Neuropsychopharmacology; 1999 Jun; 20(6):628-39. PubMed ID: 10327431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects.
    Schwartz PJ; Turner EH; Garcia-Borreguero D; Sedway J; Vetticad RG; Wehr TA; Murphy DL; Rosenthal NE
    Psychiatry Res; 1999 Apr; 86(1):9-28. PubMed ID: 10359479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder.
    Broocks A; Bandelow B; Koch K; Bartmann U; Kinkelbur J; Schweiger U; Hohagen F; Hajak G
    Neuropsychopharmacology; 2002 Aug; 27(2):270-8. PubMed ID: 12093600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ipsapirone challenge in aggressive men shows an inverse correlation between 5-HT1A receptor function and aggression.
    Cleare AJ; Bond AJ
    Psychopharmacology (Berl); 2000 Mar; 148(4):344-9. PubMed ID: 10928305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lamotrigine on the 5-HT1A receptor function in healthy human males.
    Shiah IS; Yatham LN; Lam RW; Zis AP
    J Affect Disord; 1998 May; 49(2):157-62. PubMed ID: 9609681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic treatment with an anxiolytic dose of the 5-HT1A agonist ipsapirone does not alter ipsapirone acute neuroendocrine effects.
    Schmidt BH; Chaouloff F
    Psychoneuroendocrinology; 1993; 18(7):457-66. PubMed ID: 7903466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin 1A receptor activation and hypothermia in humans: lack of evidence for a presynaptic mediation.
    Blier P; Seletti B; Gilbert F; Young SN; Benkelfat C
    Neuropsychopharmacology; 2002 Aug; 27(2):301-8. PubMed ID: 12093604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats.
    Li Q; Brownfield MS; Levy AD; Battaglia G; Cabrera TM; Van de Kar LD
    Biol Psychiatry; 1994 Sep; 36(5):300-8. PubMed ID: 7993956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blunted temperature and cortisol responses to ipsapirone in major depression: lack of enhancement by electroconvulsive therapy.
    Shapira B; Newman ME; Gelfin Y; Lerer B
    Psychoneuroendocrinology; 2000 Jul; 25(5):421-38. PubMed ID: 10818278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blunted hormone responses to Ipsapirone are associated with trait impulsivity in personality disorder patients.
    Minzenberg MJ; Grossman R; New AS; Mitropoulou V; Yehuda R; Goodman M; Reynolds DA; Silverman JM; Coccaro EF; Marcus S; Siever LJ
    Neuropsychopharmacology; 2006 Jan; 31(1):197-203. PubMed ID: 16123761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder.
    Lesch KP; Hoh A; Schulte HM; Osterheider M; Müller T
    Psychopharmacology (Berl); 1991; 105(3):415-20. PubMed ID: 1686817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.